Trizole

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trizole

Property Description
Active ingredients Sulphamethoxazole, Trimethoprim
Form Tablets, oral suspension, intravenous solution
Pharmacological class Broad-spectrum antibiotic (Antimicrobial Agent)
Common use Treating various systemic bacterial infections
Origin Synthetic

What Type of Medicine is Trizole (Co-trimoxazole)?

Trizole, formally identified as Co-trimoxazole (SMX/TMP), is a synthetic drug widely recognized as a broad-spectrum antibiotic or antimicrobial agent. This medicine is defined as a fixed-dose combination product, purposefully joining two distinct active pharmacological substances into a single preparation. The combination of Sulphamethoxazole and Trimethoprim is clinically recognized for its effectiveness against numerous infection types, supporting its inclusion in various international treatment protocols. Other brands utilizing this identical formulation include Bactrim and Septra. The general purpose of this medicine is to serve as a reliable intervention for controlling and eliminating systemic bacterial infections, such as those affecting the respiratory or urinary tracts.


Composition: Sulphamethoxazole and Trimethoprim

The composition of Trizole centers on its two distinct active ingredients: Sulphamethoxazole and Trimethoprim. Sulphamethoxazole belongs to the sulfonamide antibiotic class, while Trimethoprim is categorized as a diaminopyrimidine antibiotic. These two components are precisely blended into a single formulation to ensure synergistic antibacterial activity. This medicine is commonly manufactured in multiple dosage forms, including traditional tablets, an oral suspension often used for pediatric patients, and a professional intravenous solution reserved for hospital settings.


The General Purpose of This Synergistic Combination

The fundamental purpose of this medication is to leverage its synergistic antibacterial activity to effectively inhibit the growth and survival of target bacteria. This unique dual-agent strategy achieves a highly effective process known as sequential blockade. Pharmacological studies consistently support that by simultaneously targeting two separate, yet vital, steps in the bacteria's folic acid synthesis pathway, the fixed-dose combination provides a decisive means of stopping bacterial multiplication. This approach ensures that Trizole remains an important, effective antimicrobial agent for addressing a wide range of common bacterial infections.

Regulatory References

  1. Co-trimoxazole on the WHO Essential Medicines List (eEML)

What side effects are possible with Trizole?

Possible Side Effects and Safety Information: Trizole

The safety profile of Trizole is based on official government regulatory documents (e.g., FDA, EMA) and is organized by the frequency and type of adverse reactions observed in clinical data.

Adverse Reaction Scope

The most commonly reported side effects typically involve the Gastrointestinal System (Nausea, Vomiting, Diarrhea) and the Nervous System (Headache). These are often classified as Very Common or Common.

System-Organ Class Involved Common Adverse Reactions Frequency
Gastrointestinal Disorders Nausea, Vomiting, Diarrhea Very Common
Nervous System Disorders Headache Very Common
Hepatobiliary Disorders Elevated liver enzymes (ALT, AST) Common
Metabolism & Nutrition Low potassium (Hypokalaemia) Common

Serious Adverse Reactions and Safety Constraints

Serious Adverse Reactions (often Rare or Very Rare) require clinical vigilance as they can be life-threatening. The most significant risks documented for Trizole involve the Liver and the Heart:

  • Hepatotoxicity: The medication carries a risk of severe liver injury, including rare cases of fulminant hepatic failure. Liver function tests are required for monitoring, particularly when treatment begins.
  • Cardiac Risk (QTc Prolongation): Trizole can prolong the QTc interval, which carries a rare risk of a severe heart rhythm disturbance called Torsades de pointes. ECG monitoring may be necessary.
  • Serious Skin Reactions: Rare instances of severe skin adverse events, such as Stevens-Johnson Syndrome (SJS), have been reported.

Safety Constraints and Limitations mean the drug is contraindicated in patients with specific severe, pre-existing conditions, such as certain forms of heart failure. Use during Pregnancy or Lactation is generally restricted due to regulatory safety statements regarding potential reproductive toxicity.

Overdose and Emergency Response

Overdose and when to seek help

This section outlines information regarding Trizole overexposure, strictly based on official regulatory documentation.


Documented Overdose Presentations

Official reports indicate that Trizole overdose may present with Central Nervous System (CNS) effects such as somnolence and hallucinations, in addition to common gastrointestinal symptoms like nausea and vomiting. These documented clinical manifestations are used by healthcare providers to assess potential overexposure.


Severe Outcomes and Emergency Action

Overexposure carries a risk of serious life-threatening outcomes, including QT interval prolongation (a cardiac risk) and fatal hepatic necrosis (severe liver damage). Because of this risk, official prescribing information mandates immediate emergency action.

When to Seek Urgent Medical Help

The regulatory guidance is explicit: contact a poison control center or emergency room at once if an overdose is suspected or confirmed. This action is required regardless of whether symptoms have fully developed.


Overdose Management

No specific antidote for Trizole overdose is available. Management focuses on supportive care and the removal of the unabsorbed drug. Procedures such as gastric lavage may be employed. Since Trizole is substantially cleared by the procedure, hemodialysis may be used to decrease plasma concentrations. Close monitoring of cardiac function and liver enzymes is generally required in the clinical setting.

Therapeutic Uses of Trizole

Trizole (Co-trimoxazole) is commonly used to help manage conditions involving susceptible bacteria across several key areas of the body. It is applied in contexts where additional symptomatic support is needed to address symptoms related to bacterial activity.

This medication is commonly used to help with conditions presenting with acute episodes in the urinary tract, such as conditions presenting with systemic or localized discomfort in the urinary tract; specific gastrointestinal infections including traveler's diarrhea and shigellosis; and acute respiratory airway flare-ups, like chronic bronchitis exacerbations. It is also considered relevant for managing severe, opportunistic infections in immunocompromised individuals, notably the treatment and prevention of Pneumocystis Jirovecii Pneumonia (PJP).

“The medicine offers symptomatic relief that may help patients cope more steadily with difficult episodes and supports patients during phases of heightened discomfort.”

When symptoms cluster into patterns of distress, such as painful urination, severe diarrhea, or difficulty breathing, this medication provides supportive relief that generally assists with maintaining functional stability and contributes to easing the overall burden of symptoms.


Quick Fact: Relief for Acute Infections
Applied across domains involving heightened symptoms and is relevant when supportive symptom management is appropriate to support functional stability.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Trizole (Co-trimoxazole)?

Official regulatory information defines specific population groups who are eligible or restricted from using Trizole, based on known risks and established safety data.

Contraindicated Populations

Use is absolutely contraindicated in patients with a history of hypersensitivity to trimethoprim or sulfonamide medicines. It is also prohibited for infants less than 2 months of age. Contraindications include patients with documented megaloblastic anemia due to folate deficiency, or marked hepatic damage and severe renal insufficiency where function cannot be monitored. Trizole is also contraindicated in late-stage pregnancy (at term) and for nursing mothers.


Restricted and Conditional Use

Use is restricted for specific groups. Patients with moderate renal impairment (CrCl 15 - 30 mL/min) are only eligible with a mandated dose reduction. Older adults (ge 65 years) may use Trizole, but require particular care due to increased susceptibility to adverse effects. Caution is also advised for patients with G-6-PD deficiency or pre-existing risks for folate deficiency.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific drug–drug interactions for Trizole (Co-trimoxazole) based on its effects on metabolism and renal clearance. This section outlines formal restrictions and documented exposure changes without providing medical advice.

Contraindicated Combinations

Co-administration with Dofetilide is formally contraindicated. This restriction is due to the risk of serious ventricular arrhythmias linked to the trimethoprim component impairing the renal clearance of Dofetilide. Co-administration with Methenamine is also generally not recommended.

Pharmacokinetic and Exposure Effects

Co-trimoxazole is documented to significantly alter the concentration of several co-administered medicines, primarily by inhibiting metabolism or renal transport. It prolongs the half-life of Phenytoin and potentiates the anticoagulant effect of Warfarin, requiring close monitoring of plasma levels or International Normalized Ratio (INR). Exposure to drugs like Lamivudine, Repaglinide, and Amantadine is also increased by the trimethoprim component's effect on renal clearance.

Pharmacodynamic and Other Interactions

The co-administration of Trizole with ACE inhibitors or potassium-sparing diuretics carries a documented risk of developing clinically relevant hyperkalaemia (high potassium levels). Use with Thiazide Diuretics is associated with an increased risk of thrombocytopenia, particularly noted in elderly patients. The efficacy of Trizole may be reduced by co-administration of Folinic Acid (Leucovorin), and failures of oral contraceptives have been reported with antibiotic use.

Mechanism of Action

How Trizole Works: Mechanism of Action

Trizole’s action begins by inhibiting the enzyme CYP51 (lanosterol 14alpha-demethylase), a key target in the fungal ergosterol biosynthesis pathway. The molecule achieves this by coordinating with the heme iron within the enzyme's active site, blocking a necessary demethylation step.

This enzyme block initiates a damaging intracellular cascade that leads to the depletion of ergosterol, the essential lipid required for fungal cell membranes, and the accumulation of toxic, abnormal sterol intermediates.

These faulty components severely compromise the structural integrity and homeostasis of the fungal cell membrane, resulting in cellular leakage and inhibition of cellular proliferation. The drug’s mechanism is subject to biological constraints, including the fungus's capacity for gene mutation of the CYP51 target or the overexpression of efflux pumps, which can reduce the effective concentration within the cell.

Dosage and Administration Information

The use of Trizole (Co-trimoxazole) is strictly guided by instructions concerning administration routes, standard dosing, and treatment duration. This medicine is available in oral forms (tablets and suspension) and as a concentrate for intravenous (IV) infusion.


Administration and Dosage

Standard Dosing: The common adult regimen is one Double Strength (DS) tablet (800 mg Sulphamethoxazole/160 mg Trimethoprim) taken every 12 hours (twice daily) for acute infections. Treatment duration varies, ranging from 5 days for certain gastrointestinal infections to 10 to 14 days for many urinary or respiratory infections.

High-Dose and Specialized Use:

Usage Context Dosing Principle Duration Pattern
Treatment of PJP Based on body weight (mathbf15–20 mg/kg/day of Trimethoprim), divided into mathbf3–4 doses mathbf14–21 days
PJP Prophylaxis One DS tablet mathbfonce daily or mathbf3 times per week For the duration of the risk period

Population Adjustments: Dosing for pediatric patients (over 2 months) is weight-based. For adults with impaired renal function (CrCl 15–30 mL/min), the dose must be decreased by 50%.


Practical Administration Requirements

Fluid Intake: Oral tablets must be taken with a mathbffull glass of water, and mathbfadequate fluid intake should be maintained during the full course of therapy.

Timing: The oral form may be taken mathbfwith or mathbfwithout food.

IV Preparation: The IV concentrate must be mathbfdiluted before use and administered by mathbfslow infusion over a period of 60 to 90 minutes. Rapid intravenous injection or intramuscular use is prohibited.

Missed Dose: If a dose is missed for a twice-daily schedule, it should be taken immediately only if the time until the next dose is more than 6 hours. Do not double the dose to make up for a missed one.

Recent Clinical Evidence

Evidence for Urinary Tract and Gastrointestinal Infections

The research on Trizole (Co-trimoxazole) includes short-term Randomized Controlled Trials (RCTs) and systematic reviews for common bacterial infections. These studies primarily examine the medicine's use in studies for acute infections of the urinary and gastrointestinal tracts. Researchers explored outcomes related to physical discomfort in both non-pregnant adults and pediatric patients. Trials monitored the resolution of symptoms and the measured reduction of bacteria. Studies reported symptom patterns observed over defined, short time intervals, typically 3 to 10 days.

Evidence for Severe and Opportunistic Pneumonia (PJP)

This research is a well-established area of its research base, supported by long-term cohort studies and RCTs designed to examine outcomes related to acute PJP and the prophylaxis (prevention) of the infection. In studies focusing on treatment, research examined outcomes related to survival and the achievement of a predefined clinical response in acutely ill, immunocompromised individuals. In prophylactic studies, research explored whether the medicine was associated with changes in the measured incidence of PJP infection over extended observation periods.

Research in Specific Patient Groups and Uncertainties

The largest body of research for a special population was concentrated in the studies of PJP among immunocompromised individuals. Pediatric patients are also included in the research for multiple indications. However, long-term data are not fully established for many applications, and follow-up durations were limited in many trials. A key uncertainty relates to antimicrobial resistance; studies show patterns related to reduced susceptibility in certain regions, which was observed in some studies. Comparative evidence is lacking against the newest generation of antimicrobial agents across all indications.

Key Studies & References

  1. Pneumocystis Pneumonia: Adult and Adolescent OIs - Clinical Guidelines for Prevention and Treatment
  2. WHO Model List of Essential Medicines (Sulfamethoxazole + trimethoprim)
  3. Short-course versus conventional length antimicrobial therapy for uncomplicated lower urinary tract infections in children: a meta-analysis
  4. Trimethoprim Sulfamethoxazole - StatPearls (Review of Indications, Dosing, and Resistance)
  5. Co-trimoxazole and trimethoprim in complicated urinary tract infection (RCT)

Frequently Asked Questions (FAQ)

Common questions about Trizole (FAQ)


Q: How long does the effect of Trizole typically last in the body?

Official data indicates that the average serum half-life of the sulfamethoxazole component—one of the two active ingredients—is approximately 10 hours. This measurement is a factor in how the drug is distributed and eliminated within the body, which relates to its intended antimicrobial activity.


Q: Is a skin rash a common reaction to taking Trizole?

Yes, skin rash is noted in regulatory documents among the most common adverse effects observed during the use of Trizole. However, official information also describes rare instances of serious skin reactions that require immediate medical attention.


Q: Does Trizole have any serious but rare side effects that people should know about?

Official product information documents the possibility of very rare, serious adverse effects. These include severe conditions such as Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and haemophagocytic lymphohistiocytosis (HLH). The official product information typically describes the specific signs of these reactions that may require attention.


Q: Is it necessary to avoid alcohol while taking Trizole?

Official documentation describes a potential increased risk to the liver when Trizole is used, and alcohol consumption is known to impact liver function. This association may be mentioned as a consideration, especially for individuals with existing liver conditions.


Q: Can Trizole be safely used by women who are pregnant or planning to be?

Use of Trizole is generally restricted during pregnancy based on regulatory safety statements. The medicine is formally contraindicated, meaning it should not be used, during the last three months of pregnancy due to documented risks.


Q: Is Trizole generally considered appropriate for use during breastfeeding?

Trizole is generally contraindicated for use by nursing mothers in certain situations. This restriction applies when the infant is less than two months old, jaundiced, premature, or has a condition called glucose-6-phosphate dehydrogenase (G6PD) deficiency, due to the regulatory-documented risk of a condition called kernicterus.


Q: Can Trizole interact with hormonal birth control pills?

Official interaction sections advise that Trizole, like some other antibiotics, can alter the effect of hormonal birth control. Failures of oral contraceptives have been reported in the clinical use setting with antibiotics, and this possibility is often included in the medicine’s official warnings.


Q: Is Trizole one of the older or newer types of antimicrobial agents?

Trizole is a fixed-dose combination of two principles: sulfamethoxazole, which is a sulfonamide antibiotic, and trimethoprim, which is a diaminopyrimidine. Both of these components have been utilized in medical practice for a significant period of time.


Q: Can Trizole be used by people with known kidney issues?

Official regulatory documents state that Trizole is contraindicated in patients with severe renal insufficiency. For patients who have moderate renal impairment, use is only permitted with a mandated dose reduction and close monitoring by a healthcare professional.


Q: How is Trizole different from other common antifungal medications?

Trizole is classified in official documents as a broad-spectrum antibacterial agent, also known as an antibiotic, because it works by disrupting bacterial folic acid synthesis. It is explicitly not classified as an antifungal medicine.


Q: Can Trizole affect blood pressure or blood sugar levels?

Official adverse events reporting indicates that low blood sugar, or hypoglycemia, is a documented but rare adverse effect of Trizole. Separately, the medicine may cause an increase in potassium levels, known as hyperkalaemia, which can sometimes affect heart rhythm.


Q: Why is Trizole sometimes prescribed alongside other vitamins or supplements?

Trizole is known to potentially interfere with the body’s metabolism of folic acid (folate), which is essential for certain processes. Official documents discuss that the medicine’s noted effect on folic acid metabolism is a reason why folinic acid supplementation has been examined or is mentioned as a possible intervention in some patient populations.


Q: Does Trizole affect a person's ability to drive or operate machinery?

Regulatory documents state that Trizole may cause nervous system effects such as dizziness, confusion, or convulsions. If these effects are experienced, regulatory information states that the ability to drive or operate machinery may be impaired.


Q: Does Trizole interact with any common herbal supplements like St. John's Wort?

Official data indicates that St. John's Wort is documented to potentially reduce the blood levels of the trimethoprim component of Trizole. This reduction in concentration could, in turn, lead to a decreased effectiveness of the medicine.


Q: What is the difference between Trizole and Trizole-B or Trizole-D?

The active substance Trizole is officially known as Co-trimoxazole. Products with suffixes like '-B' or '-D' often refer to different fixed-dose combination products. These may contain a mix of an antibiotic, an antifungal, and a steroid used for a purpose other than systemic infection, such as treating a localized skin issue.


Q: Does the form of Trizole (e.g., tablet, suspension) change its list of interactions?

The major documented interactions are systemic, meaning they affect the body’s metabolism or clearance processes. Therefore, the interaction profile is generally tied to the active ingredients and applies to both oral forms (tablets and suspension) and the intravenous form.


Q: Is Trizole considered habit-forming or addictive?

Trizole is classified by regulatory authorities as an antibacterial agent (antibiotic). There are no official regulatory warnings or classifications that describe Trizole as a habit-forming or controlled substance.


Q: Are there specific signs of an allergic reaction to Trizole that require attention?

Specific signs of a potentially severe allergic reaction requiring immediate attention are noted in official warnings. These include high fever, severe headache, ulcers in the mouth or throat, and a rash that may present with blisters or mucosal lesions.


Q: Does Trizole cause sensitivity to sunlight?

Regulatory documents state that the medicine can make patients more sensitive to sun exposure, a condition known as photosensitivity. Because of this, general precautions regarding sun exposure, such as the use of protective clothing or sunscreens, are typically associated with its use.


Q: Can Trizole interact with cholesterol-lowering medicines (statins)?

Official interaction documentation for Trizole does not list a major or formal contraindication with common cholesterol-lowering medicines known as statins. As with any medication, all interaction concerns are typically discussed with a healthcare professional.


Q: What is the importance of Trizole's protein binding percentage?

The protein binding of the sulfamethoxazole component is described in official pharmacokinetics data as approximately 66%. This characteristic is a factual measurement that indicates how much of the drug is bound to proteins in the blood, which is a factor in how the drug is distributed and eliminated within the body.


Q: How do the different ingredients in combination products like Trizole-B work together?

Combination products like Trizole-B are typically used for specific localized conditions, such as a complicated skin infection. In these cases, the multiple ingredients, which may include an antifungal, an antibiotic, and a steroid, work together to address the different aspects of the infection and related inflammation.


Q: Is Trizole contraindicated with any common psychiatric medications?

Trizole is formally contraindicated with the medication Dofetilide due to a serious heart risk. While the interaction with broader psychiatric medication classes like tricyclic antidepressants has been explored in clinical literature, this is not a formal contraindication on regulatory labels.

How should Trizole be stored and disposed of?

Storage and Disposal of Trizole (Co-trimoxazole)

Official regulatory guidelines strictly define the conditions required to store Trizole (sulphamethoxazole and trimethoprim) and ensure its proper disposal.

Storage Conditions

Requirement Details
Temperature Store tablets and oral suspension at temperatures not exceeding 30 C.
Protection Keep the medicine protected from light and away from excess heat and moisture.
Containers Store tablets in their original packaging; keep the oral suspension container tightly closed.
Child Safety Like all medications, Trizole must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired Trizole must be disposed of according to local requirements and must not be discarded into household waste or wastewater. Consult a pharmacist for guidance on safe disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Trizole found in:

A-Z Index: